SCHEMBL30998328

SCHEMBL30998328

CCc1ccnc(C(=O)O)c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
GABRP O00591 4/20 0.42
GABRD O14764 4/20 0.42
GABRA1 P14867 4/20 0.42
GABRB1 P18505 4/20 0.42
GABRG2 P18507 4/20 0.42
GABRB3 P28472 4/20 0.42
GABRA5 P31644 4/20 0.42
GABRA3 P34903 4/20 0.42
GABRA2 P47869 4/20 0.42
GABRB2 P47870 4/20 0.42
GABRA4 P48169 4/20 0.42
GABRE P78334 4/20 0.42
GABRA6 Q16445 4/20 0.42
GABRG1 Q8N1C3 4/20 0.42
GABRG3 Q99928 4/20 0.42
GABRQ Q9UN88 4/20 0.42
ASPH Q12797 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7436030 0.88 KDM4E (0.40) KDM4EMAPTCYP1A2GABRPGABRD
SCHEMBL20579524 0.85 MAP2K3 (0.40) KDM4ECYP1A2GABRPGABRDGABRA1
SCHEMBL29865435 0.81 BRD4 (0.47) KDM4EMAPTCYP1A2ALOX15L3MBTL1
SCHEMBL23137481 0.80 PRKCI (0.35) CYP1A2GABRPGABRDGABRA1GABRB1
SCHEMBL14895438 0.80 BRD4 (0.48) KDM4EMAPTCYP1A2ALOX15L3MBTL1
SCHEMBL10694897 0.79 KDM4E (0.47) KDM4EMAPTCYP1A2GABRPGABRD
SCHEMBL29099630 0.79 KDM4E (0.44) KDM4EMAPTCYP1A2GABRPGABRD
SCHEMBL5820837 0.79 KDM4E (0.44) KDM4EMAPTCYP1A2GABRPGABRD
SCHEMBL868001 0.79 KDM4E (0.44) KDM4EMAPTCYP1A2GABRPGABRD
SCHEMBL8645026 0.78 KDM4E (0.46) KDM4EMAPTCYP1A2GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646271-A1 SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES Mirati Therapeutics, Inc. (US) 2025-11-12 EP disclosed
WO-2024148150-A1 SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES Mirati Therapeutics, Inc. (US) 2024-07-11 WO disclosed